| 1. |
陳露露, 田亞瓊, 張英為, 等. 繼發于血液系統疾病的肺泡蛋白沉積癥三例報告并文獻復習. 中國呼吸與危重監護雜志, 2004, 3(1): 34-36.
|
| 2. |
Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis. N Engl J Med, 2003(349): 2527-2539.
|
| 3. |
Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med, 1999, 190(6): 875-880.
|
| 4. |
Tanaka T, Motoi N, Tsuchihashi Y, et al. Adult-onset hereditary pulmonary alveolar proteinosis caused by a single-base deletion in CSF2RB. J Med Genet, 2011, 48(3): 205-209.
|
| 5. |
Campo I, Mariani F, Rodi G, et al. Assessment and management of pulmonary alveolar proteinosis in a reference center. Orphanet J Rare Dis, 2013, 8: 40.
|
| 6. |
Inoue Y, Trapnell BC, Tazawa R, et al. Characteristics of a large cohort of autoimmune pulmonary alveolar proteinosis patients in Japan. Am J Respir Crit Care Med, 2008, 177(7): 752-762.
|
| 7. |
Ishii H, Trapnell BC, Tazawa R, et al. Comparative study of high resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis. Chest, 2009, 136(5): 1348-1355.
|
| 8. |
Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med, 2002(166): 215-235.
|
| 9. |
Seymour JF, Dunn AR, Vincent JM, et al. Efficacy of granulocyte-macrophage colony-stimulating factor in acquired alveolar proteinosis. N Engl J Med, 1996, 335(25): 1924-1925.
|
| 10. |
Tazawa R, Trapnell BC, Inoue Y, et al. Inhaled granulocyte/ macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. Am J Respir Crit Care Med, 2010, 181(12): 1345-1354.
|
| 11. |
詹永忠, 田欣倫, 徐凱峰. 粒細胞巨噬細胞集落刺激因子吸入治療重癥自身免疫性肺泡蛋白沉積癥一例. 中國醫學科學院學報, 2015, 37(5): 628-630.
|
